79
67
Growth Score 79 in past quarter
-7 pts
Heat Score 67 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
415269
Theragen Bio is a genome service provider and AI-based biopharmaceutical company.
- Taesoon Hwang: CEO and President
- Yoon Dong-hyun: CFO
About the Company
Theragen Bio offers a software platform for NGS and genome and transcriptome analysis. The business offers next-generation sequencing equipment like the NovaSeq 6000, HiSeq 4000, Ion S5 XL, Ion proton, Ion PGM, and MiSeqDx. The company uses QuanStudio, Fludigm, BeadXpress, GeneTitan, and LC480 as its genotyping platforms. It provides services for
research, diagnostics, and healthcare.